http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0804176-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dfae81468523c4a7e635145a1bfe2359
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7092
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
filingDate 1995-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07f5cf787f98ff645f48450adb24bb14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0fb1caa8684aa1ebdad5b0f4c83df67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e7ee520fc40f4c1506d79d2deb9b3c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19796bf6d1cdae92f9d3d77070626ef5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02a2684e1fc0773fd09baf54b7bcd3e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe3c15dcb11cb98f6c8531ebfed6e249
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b0841274bd49a6e7570e4edb8f603b4
publicationDate 1997-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0804176-A1
titleOfInvention Transdermal presentation of nitroglycerin for preventing undesired labour
abstract PCT No. PCT/EP95/00654 Sec. 371 Date Jul. 1, 1997 Sec. 102(e) Date Jul. 1, 1997 PCT Filed Feb. 22, 1995 PCT Pub. No. WO95/22964 PCT Pub. Date Aug. 31, 1995The pharmaceutical use of nitroglycerin, which is also designated as glycerol trinitrate or, chemically, as 1,2,3-propanetriol trinitrate, in a transdermal application form prevents undesired labour in pregnant mammals. The pharmaceutical use prevents premature labour.
priorityDate 1994-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127380029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20405225
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4510
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129261279
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227375498
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21806056
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226729506

Total number of triples: 34.